Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM
- 1 May 1996
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 45 (5) , 622-626
- https://doi.org/10.2337/diabetes.45.5.622
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: